[1]
Hiremath, S.B. and Gandigawad, P. 2016. Effects of selective imidazolin-1 receptor agonists’ vs Dihydropyridine calcium channel blockers on insulin resistance in patients of hypertension with metabolic syndrome: a meta-analysis of randomized controlled trials. International Journal of Basic & Clinical Pharmacology. 5, 2 (Dec. 2016), 394–401. DOI:https://doi.org/10.18203/2319-2003.ijbcp20160751.